Literature DB >> 25669480

Infliximab therapy in two cases of severe neurotuberculosis paradoxical reaction.

James S Molton1, Paul J Huggan, Sophia Archuleta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25669480     DOI： 10.5694/mja14.00716

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  8 in total

1.  Neurotuberculosis: Control of Steroid-Refractory Paradoxical Inflammatory Reaction With Ruxolitinib.

Authors:  Yingda L Xie; Fanny Ita-Nagy; Ray Y Chen; Maura M Manion; Irini Sereti; Luxin Pei; Steven M Holland
Journal:  Open Forum Infect Dis       Date:  2019-10-26       Impact factor: 3.835

Review 2.  Advances in the Diagnosis and Management of Tubercular Meningitis in Children.

Authors:  Himani Bhasin; Medha Goyal; Suvasini Sharma
Journal:  Indian J Pediatr       Date:  2019-12-04       Impact factor: 1.967

Review 3.  Treatment of Tuberculous Meningitis and Its Complications in Adults.

Authors:  Angharad Davis; Graeme Meintjes; Robert J Wilkinson
Journal:  Curr Treat Options Neurol       Date:  2018-02-28       Impact factor: 3.598

4.  Late-onset paradoxical reactions 10 years after treatment for tuberculous meningitis in an HIV-negative patient: a case report.

Authors:  Akira Machida; Tasuku Ishihara; Eiichiro Amano; Shinichi Otsu
Journal:  BMC Infect Dis       Date:  2018-07-06       Impact factor: 3.090

Review 5.  Corticosteroids for managing tuberculous meningitis.

Authors:  Kameshwar Prasad; Mamta B Singh; Hannah Ryan
Journal:  Cochrane Database Syst Rev       Date:  2016-04-28

6.  Corticosteroid therapy for the management of paradoxical inflammatory reaction in patients with pulmonary tuberculosis.

Authors:  Macky M Done; Onno W Akkerman; Wud Al-Kailany; Wiel C M de Lange; Gonda de Jonge; Johanneke Kleinnijenhuis; Riejanne Stienstra; Tjip S van der Werf
Journal:  Infection       Date:  2020-04-24       Impact factor: 3.553

Review 7.  The current global situation for tuberculous meningitis: epidemiology, diagnostics, treatment and outcomes.

Authors:  James A Seddon; Lillian Tugume; Regan Solomons; Kameshwar Prasad; Nathan C Bahr
Journal:  Wellcome Open Res       Date:  2019-11-05

Review 8.  Tumor necrosis factor antagonists for paradoxical inflammatory reactions in the central nervous system tuberculosis: Case report and review.

Authors:  Miguel Santin; Cristina Escrich; Carles Majòs; Mariona Llaberia; Maria D Grijota; Imma Grau
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.